Max D. Wellenstein

3.5k total citations · 3 hit papers
10 papers, 2.3k citations indexed

About

Max D. Wellenstein is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Max D. Wellenstein has authored 10 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Max D. Wellenstein's work include Immune cells in cancer (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immunotherapy and Immune Responses (3 papers). Max D. Wellenstein is often cited by papers focused on Immune cells in cancer (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immunotherapy and Immune Responses (3 papers). Max D. Wellenstein collaborates with scholars based in Netherlands, United States and United Kingdom. Max D. Wellenstein's co-authors include Karin E. de Visser, Seth B. Coffelt, Cheei‐Sing Hau, Kim Vrijland, Lodewyk F.A. Wessels, Danique E. M. Duits, Ton N. Schumacher, Linda Henneman, Wilbert Zwart and Jos Jonkers and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature reviews. Cancer.

In The Last Decade

Max D. Wellenstein

10 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutrophils in cancer: neutral no more

2016 1.3k citations Seth B. Coffelt, Max D. Wellenstein et al. Nature reviews. Cancer profile →
Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape

2018 413 citations Max D. Wellenstein, Karin E. de Visser Immunity profile →
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis

2019 361 citations Max D. Wellenstein, Seth B. Coffelt et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Max D. Wellenstein Netherlands	9	1.3k	1.3k	691	394	307	10	2.3k
Ludmila Umansky Germany	18	1.3k 1.1×	1.5k 1.2×	634 0.9×	255 0.6×	264 0.9×	21	2.4k
Sangeeta Goswami United States	19	1.2k 0.9×	1.2k 1.0×	801 1.2×	314 0.8×	626 2.0×	57	2.7k
Cara Haymaker United States	27	1.6k 1.3×	1.4k 1.1×	605 0.9×	246 0.6×	313 1.0×	130	2.5k
Audrey Lupo France	20	1.7k 1.3×	1.5k 1.2×	597 0.9×	322 0.8×	693 2.3×	44	2.8k
Huaxiang Xu China	23	1.0k 0.8×	662 0.5×	735 1.1×	477 1.2×	281 0.9×	54	2.1k
Dario Sangiolo Italy	25	1.4k 1.1×	1.1k 0.9×	549 0.8×	200 0.5×	442 1.4×	76	2.2k
Christopher Groth Germany	14	1.1k 0.9×	1.5k 1.2×	584 0.8×	240 0.6×	187 0.6×	18	2.1k
Julie Decock Qatar	23	1.1k 0.8×	613 0.5×	761 1.1×	659 1.7×	229 0.7×	49	2.0k
Sydney Gordon United States	8	1.4k 1.1×	1.7k 1.4×	740 1.1×	210 0.5×	293 1.0×	10	2.8k
France Bourdeau Canada	13	735 0.6×	1.4k 1.1×	453 0.7×	264 0.7×	205 0.7×	21	2.0k

Countries citing papers authored by Max D. Wellenstein

Since Specialization

Citations

This map shows the geographic impact of Max D. Wellenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max D. Wellenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max D. Wellenstein more than expected).

Fields of papers citing papers by Max D. Wellenstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max D. Wellenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max D. Wellenstein. The network helps show where Max D. Wellenstein may publish in the future.

Co-authorship network of co-authors of Max D. Wellenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Max D. Wellenstein. A scholar is included among the top collaborators of Max D. Wellenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max D. Wellenstein. Max D. Wellenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Blomberg, Olga, Kevin Kos, Lorenzo Spagnuolo, et al.. (2023). Neoadjuvant immune checkpoint blockade triggers persistent and systemic T _reg activation which blunts therapeutic efficacy against metastatic spread of breast tumors. OncoImmunology. 12(1). 2201147–2201147. 11 indexed citations

2.

Hassin, Ori, Felix C. E. Vogel, Max D. Wellenstein, et al.. (2023). p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cells. Proceedings of the National Academy of Sciences. 120(52). e2311460120–e2311460120. 6 indexed citations

3.

Yeung, Jake, Maria Florescu, Peter Zeller, et al.. (2023). scChIX-seq infers dynamic relationships between histone modifications in single cells. Nature Biotechnology. 41(6). 813–823. 23 indexed citations

4.

Kos, Kevin, Muhammad Assad Aslam, Rieneke van de Ven, et al.. (2022). Tumor-educated Tregs drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche. Cell Reports. 38(9). 110447–110447. 39 indexed citations

5.

Kos, Kevin, Camilla Salvagno, Max D. Wellenstein, et al.. (2022). Tumor-associated macrophages promote intratumoral conversion of conventional CD4 ⁺ T cells into regulatory T cells via PD-1 signalling. OncoImmunology. 11(1). 2063225–2063225. 23 indexed citations

6.

Wellenstein, Max D., Seth B. Coffelt, Danique E. M. Duits, et al.. (2019). Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis. Nature. 572(7770). 538–542. 361 indexed citations breakdown →

7.

Wellenstein, Max D. & Karin E. de Visser. (2018). Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape. Immunity. 48(3). 399–416. 413 indexed citations breakdown →

8.

Kersten, Kelly, Seth B. Coffelt, Marlous Hoogstraat, et al.. (2017). Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophages. OncoImmunology. 6(8). e1334744–e1334744. 85 indexed citations

9.

Stawowczyk, Marcin, Max D. Wellenstein, Sharrell B. Lee, et al.. (2016). Matrix Metalloproteinase 14 promotes lung cancer by cleavage of Heparin-Binding EGF-like Growth Factor. Neoplasia. 19(2). 55–64. 48 indexed citations

10.

Coffelt, Seth B., Max D. Wellenstein, & Karin E. de Visser. (2016). Neutrophils in cancer: neutral no more. Nature reviews. Cancer. 16(7). 431–446. 1306 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact